Danaher recently announced a collaboration with NVIDIA to combine its instruments, automation and workflow software with NVIDIA’s accelerated computing and AI platforms, alongside plans for an AI-powered autonomous lab at Abcam focused on faster development of custom antibodies and molecular tools. This push into AI-enabled science and autonomous labs directly targets Danaher’s core operating model, tying future demand for consumables and instruments to more automated, data rich research...